February 6, 2017
Ablynx submits its thrombosis antibody to EMA
Ablynx has applied its caplacizumab to European Medicines Agency for approval to use it for a form of blod clotting disorder.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Ablynx
January 26, 2017
Ablynx, Merck KGaA report encouraging results from psoriasis treatment study
Ablynx and Merck KGaA (Germany) have reported encouraging results from a study in psoriasis patients with the bi-specific Nanobody anti-IL-17A/F (M1095), via a clinical trials website (https://clinicaltrials.gov/NCT02156466).
January 24, 2017
Short: Van Herk Investments announces 10.07% Shareholding in Ablynx
Van Herk Investments B.V. has become owner of more than 10% of Ablynx as it has crossed the 10% threshold and now…
January 18, 2017
Ablynx issues additional common shares as result of warrant exercise
Ablynx has issued additional 154,342 common shares in exchange for EUR1,011,939.05 as the result of the exercise of warrants.
January 12, 2017
Ablynx starts Phase IIb RESPIRE study of RSV infections treatment
Ablynx has dosed the first patient in the Phase IIb “RESPIRE” dose-ranging efficacy study of ALX-0171, its novel inhaled drug…
December 23, 2016
FMR LLC shareholding in Ablynx slightly increases
Ablynx has received a notification of shareholdings from FMR LLC, according to which its stake in Ablynx has slightly increased.
October 21, 2016
Ablynx announces warrant exercise
Ablynx today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 10,050 common shares have been issued by the Company in exchange for EUR47,303 as the result of the exercise of warrants.
October 12, 2016
Ablynx, Merck further extend their collaboration on ion channel research, Ablynx gets €1M
Ablynx has extended for a second time its research collaboration with a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, known as MSD outside the United States and Canada, to develop and commercialise Nanobody candidates directed towards an undisclosed voltage gated ion channel.